Loading clinical trials...
Loading clinical trials...
Tirofiban With Sequential Dual Antiplatelet Therapy Versus Dual Antiplatelet Therapy Alone in Mild Acute Ischemic Stroke (TiMIS): A Multicenter, Open-Label, Blinded-Endpoint, Parallel-Controlled, Randomized Clinical Trial
Conditions
Interventions
Tirofiban+Oral Dual Antiplatelet Therapy
Oral Dual Antiplatelet Therapy
Locations
18
China
Suzhou Municipal Hospital of Anhui Province
Suzhou, Anhui, China
Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Taikang Xian People's Hospital
Zhoukou, Henan, China
WuYuan County People's Hospital
Bayan Nur, Inner Mongolia, China
Huai'an First People's Hospital
Huai'an, Jiangsu, China
Jiangsu Province (Suqian) Hospital
Suqian, Jiangsu, China
Start Date
August 30, 2025
Primary Completion Date
February 28, 2027
Completion Date
May 31, 2027
Last Updated
July 31, 2025
Lead Sponsor
Second Affiliated Hospital of Soochow University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions